Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 16 to 30 of 8134 results

  1. Board

    Our board sets out our strategic priorities and policies.

  2. Taking a proportionate approach to technology appraisals

    Find out more about NICE's new proportionate approach to technology appraisals

  3. Remdesivir and tixagevimab plus cilgavimab for treating COVID-19 (TA971)

    Evidence-based recommendations on remdesivir (Veklury) and tixagevimab plus cilgavimab (Evusheld) for treating COVID-19.

  4. COVID-19 rapid guideline: managing COVID-19 (NG191)

    This guideline covers managing COVID-19 in babies, children, young people and adults in community and hospital settings. It includes recommendations on communication, assessment, therapeutics for COVID-19, non-invasive respiratory support, preventing and managing acute complications, and identifying and managing co-infections.

  5. How to apply to join a committee

    We're excited that you're interested in joining a committee and helping us improve health and social care services. By joining, you'll have the...

  6. Selinexor with dexamethasone for treating relapsed or refractory multiple myeloma after 4 or more treatments (TA970)

    Evidence-based recommendations on selinexor (Nexpovio) with dexamethasone for treating relapsed or refractory multiple myeloma after 4 or more treatments in adults.

  7. Medical technologies advisory committee members

    Find out more about the medical technologies advisory committee members by reading their biographies. Dr Jacob Brown (chair) Biography Jacob

  8. Improved deal signals NICE recommendation of sickle cell treatment voxelotor

    Around 4,000 people with sickle cell disease could benefit from a new treatment recommended by NICE in final draft guidance.

  9. What is the effectiveness of hormone-modifying agents in the treatment of acne vulgaris?

    Recommendation ID NG198/8 Question What is the effectiveness of hormone-modifying agents in the treatment of acne vulgaris? Any explanatory

  10. What is the effect of dietary interventions or dietary changes on acne?

    Recommendation ID NG198/3 Question What is the effect of dietary interventions or dietary changes on acne? Any explanatory notes(if

  11. What is the effectiveness of physical treatments (such as light devices) in the treatment of acne vulgaris or persistent acne vulgaris-related scarring?

    Recommendation ID NG198/5 Question What is the effectiveness of physical treatments (such as light devices) in the treatment of acne vulgaris

  12. What is the effectiveness of chemical peels for the treatment of acne vulgaris or persistent acne vulgaris-related scarring?

    Recommendation ID NG198/7 Question What is the effectiveness of chemical peels for the treatment of acne vulgaris or persistent acne vulgaris-related

  13. Middle meningeal artery embolisation for chronic subdural haematomas should be used only in research. Find out what only in research means on the NICE interventional procedures guidance page.

    Recommendation ID IPG779 Question Middle meningeal artery embolisation for chronic subdural haematomas should be used only in research

  14. What is the effectivness of stains and/or other lipid-lowering treatment in people with type 1 diabetes?

    Recommendation ID NG238/3 Question What is the effectivness of stains and/or other lipid-lowering treatment in people with type 1 diabetes